PROFESSIONAL EDITION

The largest community of pharma leaders

Subscribe to Our News!

Admin

5132 articles
Look Who’s On the Move!

GenEdit Expands Leadership Team to Advance Targeted Genetic Medicines into Clinical Trials

Admin -
Industry News

Veklury® (Remdesivir) Significantly Reduced Risk of Hospitalization in High-Risk Patients with COVID-19

Admin -
Industry News

EXKIVITY® (mobocertinib) Approved for Previously-Treated Adult Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Insertion...

Admin -
Industry News

Cyclica and IMPACT Therapeutics Team Up to Advance Differentiated Anti-cancer Drug Development

Admin -
Regulatory Affairs

Incyte Announces FDA Approval of Jakafi® (ruxolitinib) for Treatment of Chronic Graft-Versus-Host Disease (GVHD)

Admin -
Look Who’s On the Move!

Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Two New Board Members

Admin -
Regulatory Affairs

Seagen and Genmab Announce FDA Accelerated Approval for TIVDAK™ (tisotumab vedotin-tftv) in Previously Treated Recurrent or Metastatic Cervical Cancer

Admin -
Industry News

Poxel Completes Enrollment in Phase 2 NASH Trial for PXL065 (DESTINY-1) in Biopsy-Proven Patients

Admin -
1234...642Page 3 of 642

Admin

https://magazine.pharmamkt.net

2021 © Copyright - TPMG